VITROS Immunodiagnostic Products NT-proBNP II

计划入组 3,246 人 · 首次发布于 2018 年 6 月 7 日

VITROS Immunodiagnostic Products hs Troponin I

计划入组 1,630 人 · 首次发布于 2018 年 7 月 10 日

Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment

计划入组 10 人 · 首次发布于 2005 年 9 月 20 日

Recombinant oncolytic virus M1(Guangzhou Vitron)

Cipros 10

Nitrous oxide(Alnox)

<dd class="col-xl-8 col-md-9 col-sm-8">N₂O</dd>

Viatris

India

NITROUS OXIDE

United States

VIATRIS HEALTHCARE

France

QuidelOrtho's VITROS Syphilis Assay Receives FDA Approval to Combat Syphilis Epidemic

QuidelOrtho and BÜHLMANN Launch Rapid Gastrointestinal Biomarker Assays for IBD and Pancreatic Insufficiency Diagnosis

QuidelOrtho Partners with Lifotronic Technology to Expand Global Immunoassay Portfolio